RefuelBio ApS

CVR44960907

Core data

Name
RefuelBio ApS
Address
Nordre Fasanvej 215, 2000, Frederiksberg
Founded
Jul 1, 2024
Employees (CVR)
4
Locations (P-units)
1View locations
Branch
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)

Keep track of RefuelBio ApS

Get an email when we detect changes to financial reports, ownership or management. Save yourself checking the company again.
Free account

Description

RefuelBio ApS’ primary activity consists of early-stage research and development of a novel medical drug candidate aimed at preventing muscle loss. The Company focuses on conditions where weight loss is accompanied by muscle loss, including obesity, type 2 diabetes, and other related medical indications. At present, the Company does not generate significant commercial revenue, as its activities are primarily related to research and development.

Financials

Company financials
Reporting period
2025DKK
Gross profit
-13,452,308
Operating profit
-14,170,662
Profit before tax
-13,736,161
Net income
-10,526,976
Total assets
23,133,856
Equity
20,574,053
Avg. employees
1
2024–2025

Unlock financial history

Datapublica Risk Score

Locked
Assesses the risk of financial distress using the company’s accounts, history, and connections.
Company score
0 · Low100 · High

What goes into the assessment

  • Financials

  • Accounts and history

  • Owners and management

  • Company and connections

Standard: Score and risk bandPro: Also a detailed explanation of the factors

Contact

No contact details have been registered for this company.

Gazelle

Loading gazelle status…

Børsen Gazelle is Dagbladet Børsen's award. Datapublica is not affiliated with Børsen. Calculated statuses are Datapublica's own analysis of public CVR financial-statement data.

People

Emmanuelle CoutanceauRoles
Board
TitlesBESTYRELSESMEDLEM
Gabor GyulvesziRoles
Board
TitlesBESTYRELSESMEDLEM
Thomas Gundelund RasmussenRoles
Management
TitlesADM. DIR.

Auditor

EY Godkendt RevisionspartnerselskabAuditorAnders Roe EriksenRoleState Authorised Public AccountantFromJun 18, 2026
EY Godkendt RevisionspartnerselskabAuditorRasmus Bloch JespersenRoleState Authorised Public AccountantFromJun 18, 2026
Ownership66.67–89.99 %Voting rights66.67 %FromJun 23, 2025

Unknown Other Participant

Ownership25–33.32 %Voting rights25 %FromApr 24, 2026

Ultimate owners

NOVO NORDISK FONDEN
Ownership through
66.67–89.99 %
🇺🇸Age1 Fund I, LP
Ownership through
Direct
25–33.32 %

Official sources